MeSH Review:
Cytogenetics
- Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group. Guilhot, F., Chastang, C., Michallet, M., Guerci, A., Harousseau, J.L., Maloisel, F., Bouabdallah, R., Guyotat, D., Cheron, N., Nicolini, F., Abgrall, J.F., Tanzer, J. N. Engl. J. Med. (1997)
- Fragile X syndrome without CCG amplification has an FMR1 deletion. Gedeon, A.K., Baker, E., Robinson, H., Partington, M.W., Gross, B., Manca, A., Korn, B., Poustka, A., Yu, S., Sutherland, G.R. Nat. Genet. (1992)
- Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A., Levine, R., Vermeesch, J.R., Stul, M., Dutta, B., Boeckx, N., Bosly, A., Heimann, P., Uyttebroeck, A., Mentens, N., Somers, R., MacLeod, R.A., Drexler, H.G., Look, A.T., Gilliland, D.G., Michaux, L., Vandenberghe, P., Wlodarska, I., Marynen, P., Hagemeijer, A. Nat. Genet. (2004)
- Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Artandi, S.E., Chang, S., Lee, S.L., Alson, S., Gottlieb, G.J., Chin, L., DePinho, R.A. Nature (2000)
- Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Naylor, S.L., Johnson, B.E., Minna, J.D., Sakaguchi, A.Y. Nature (1987)
- HRAS1-selected chromosome transfer generates markers that colocalize aniridia- and genitourinary dysplasia-associated translocation breakpoints and the Wilms tumor gene within band 11p13. Porteous, D.J., Bickmore, W., Christie, S., Boyd, P.A., Cranston, G., Fletcher, J.M., Gosden, J.R., Rout, D., Seawright, A., Simola, K.O. Proc. Natl. Acad. Sci. U.S.A. (1987)
- Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Hamel, B.C., Smits, A.P., de Graaff, E., Smeets, D.F., Schoute, F., Eussen, B.H., Knight, S.J., Davies, K.E., Assman-Hulsmans, C.F., Oostra, B.A. Am. J. Hum. Genet. (1994)
- Possible genetic damage in the Czech nuclear power plant workers. Sram, R.J., Rössner, P., Rubes, J., Beskid, O., Dusek, Z., Chvatalova, I., Schmuczerova, J., Milcova, A., Solansky, I., Bavorova, H., Ocadlikova, D., Kopecna, O., Musilova, P. Mutat. Res. (2006)
- Rett-like syndrome in fragile X syndrome. Alembik, Y., Dott, B., Stoll, C. Genetic counseling (Geneva, Switzerland) (1995)
- The BCR-ABL story: bench to bedside and back. Wong, S., Witte, O.N. Annu. Rev. Immunol. (2004)
- Dopa decarboxylase (Ddc) affects variation in Drosophila longevity. De Luca, M., Roshina, N.V., Geiger-Thornsberry, G.L., Lyman, R.F., Pasyukova, E.G., Mackay, T.F. Nat. Genet. (2003)
- Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Bassing, C.H., Suh, H., Ferguson, D.O., Chua, K.F., Manis, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., Alt, F.W. Cell (2003)
- Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. d'Adda di Fagagna, F., Hande, M.P., Tong, W.M., Lansdorp, P.M., Wang, Z.Q., Jackson, S.P. Nat. Genet. (1999)
- Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Yu, S., Mangelsdorf, M., Hewett, D., Hobson, L., Baker, E., Eyre, H.J., Lapsys, N., Le Paslier, D., Doggett, N.A., Sutherland, G.R., Richards, R.I. Cell (1997)
- A point mutation in the FMR-1 gene associated with fragile X mental retardation. De Boulle, K., Verkerk, A.J., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Van den Bos, F., de Graaff, E., Oostra, B.A., Willems, P.J. Nat. Genet. (1993)
- Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib. Lin, F., Drummond, M., O'Brien, S., Cervantes, F., Goldman, J., Kaeda, J. Blood (2003)
- Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. Braziel, R.M., Launder, T.M., Druker, B.J., Olson, S.B., Magenis, R.E., Mauro, M.J., Sawyers, C.L., Paquette, R.L., O'Dwyer, M.E. Blood (2002)
- Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q 11 variants. Dow, L.W., Tachibana, N., Raimondi, S.C., Lauer, S.J., Witte, O.N., Clark, S.S. Blood (1989)
- A novel diagnostic screen for defects in the Fanconi anemia pathway. Shimamura, A., de Oca, R.M., Svenson, J.L., Haining, N., Moreau, L.A., Nathan, D.G., D'Andrea, A.D. Blood (2002)
- Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Bardeesy, N., Falkoff, D., Petruzzi, M.J., Nowak, N., Zabel, B., Adam, M., Aguiar, M.C., Grundy, P., Shows, T., Pelletier, J. Nat. Genet. (1994)
- Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Parrish, J.E., Oostra, B.A., Verkerk, A.J., Richards, C.S., Reynolds, J., Spikes, A.S., Shaffer, L.G., Nelson, D.L. Nat. Genet. (1994)
- Physical map and organization of Arabidopsis thaliana chromosome 4. Schmidt, R., West, J., Love, K., Lenehan, Z., Lister, C., Thompson, H., Bouchez, D., Dean, C. Science (1995)
- Sister chromatid exchange frequency in asbestos workers. Rom, W.N., Livingston, G.K., Casey, K.R., Wood, S.D., Egger, M.J., Chiu, G.L., Jerominski, L. J. Natl. Cancer Inst. (1983)
- Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. Herrmann, M.A., Hay, I.D., Bartelt, D.H., Ritland, S.R., Dahl, R.J., Grant, C.S., Jenkins, R.B. J. Clin. Invest. (1991)
- Use of heparin in the collection of bone-marrow aspirates for cytogenetic studies. Hagemeijer, A. N. Engl. J. Med. (1981)
- Hematologic neoplasia associated with primary mediastinal germ-cell tumors. Nichols, C.R., Roth, B.J., Heerema, N., Griep, J., Tricot, G. N. Engl. J. Med. (1990)
- An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture. Cornelissen, J.J., Ploemacher, R.E., Wognum, B.W., Borsboom, A., Kluin-Nelemans, H.C., Hagemeijer, A., Löwenberg, B. J. Clin. Invest. (1998)
- Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Sorensen, P.H., Wu, J.K., Berean, K.W., Lim, J.F., Donn, W., Frierson, H.F., Reynolds, C.P., López-Terrada, D., Triche, T.J. Proc. Natl. Acad. Sci. U.S.A. (1996)
- 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Morales, J.C., Franco, S., Murphy, M.M., Bassing, C.H., Mills, K.D., Adams, M.M., Walsh, N.C., Manis, J.P., Rassidakis, G.Z., Alt, F.W., Carpenter, P.B. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Implications of fragile X expression in normal males for the nature of the mutation. Ledbetter, D.H., Ledbetter, S.A., Nussbaum, R.L. Nature (1986)
- Saccharin-induced sister chromatid exchanges in Chinese hamster and human cells. Wolff, S., Rodin, B. Science (1978)
- Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine. MacGregor, J.T., Schlegel, R., Wehr, C.M., Alperin, P., Ames, B.N. Proc. Natl. Acad. Sci. U.S.A. (1990)
- Genetic, cytogenetic, and molecular analyses of mutations induced by melphalan demonstrate high frequencies of heritable deletions and other rearrangements from exposure of postspermatogonial stages of the mouse. Russell, L.B., Hunsicker, P.R., Cacheiro, N.L., Rinchik, E.M. Proc. Natl. Acad. Sci. U.S.A. (1992)
- Isolation and characterization of two new drosophila protein kinase C genes, including one specifically expressed in photoreceptor cells. Schaeffer, E., Smith, D., Mardon, G., Quinn, W., Zuker, C. Cell (1989)
- Transcription factors in disease. Engelkamp, D., van Heyningen, V. Curr. Opin. Genet. Dev. (1996)
- Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Debiec-Rychter, M., Cools, J., Dumez, H., Sciot, R., Stul, M., Mentens, N., Vranckx, H., Wasag, B., Prenen, H., Roesel, J., Hagemeijer, A., Van Oosterom, A., Marynen, P. Gastroenterology (2005)
- XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. Clemson, C.M., McNeil, J.A., Willard, H.F., Lawrence, J.B. J. Cell Biol. (1996)
- Two new cases of FMR1 deletion associated with mental impairment. Hirst, M., Grewal, P., Flannery, A., Slatter, R., Maher, E., Barton, D., Fryns, J.P., Davies, K. Am. J. Hum. Genet. (1995)
- Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. Talpaz, M., Estrov, Z., Kantarjian, H., Ku, S., Foteh, A., Kurzrock, R. J. Clin. Invest. (1994)
- Xenograft model of progressive human proliferative breast disease. Miller, F.R., Soule, H.D., Tait, L., Pauley, R.J., Wolman, S.R., Dawson, P.J., Heppner, G.H. J. Natl. Cancer Inst. (1993)
- Role of fibroblast growth factor receptor signaling in prostate cancer cell survival. Ozen, M., Giri, D., Ropiquet, F., Mansukhani, A., Ittmann, M. J. Natl. Cancer Inst. (2001)
- Succinyl CoA: 3-oxoacid CoA transferase (SCOT): human cDNA cloning, human chromosomal mapping to 5p13, and mutation detection in a SCOT-deficient patient. Kassovska-Bratinova, S., Fukao, T., Song, X.Q., Duncan, A.M., Chen, H.S., Robert, M.F., Pérez-Cerdá, C., Ugarte, M., Chartrand, C., Vobecky, S., Kondo, N., Mitchell, G.A. Am. J. Hum. Genet. (1996)
- Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Miller, W.H., Kakizuka, A., Frankel, S.R., Warrell, R.P., DeBlasio, A., Levine, K., Evans, R.M., Dmitrovsky, E. Proc. Natl. Acad. Sci. U.S.A. (1992)